Gilead Sciences

House progressives challenge drugmakers to come back to Capitol Hill
House progressives challenge drugmakers to come back to Capitol Hill
Stat
Democrats
drug pricing
Pfizer
Merck
Eli Lilly
Gilead Sciences
Mylan
Mallinckrodt
Flag link:
Influential task force urges payers to cover PrEP for HIV
Influential task force urges payers to cover PrEP for HIV
Healthcare Dive
HIV
PrEP
Gilead Sciences
Truvada
Affordable Care Act
US Preventive Services Task Force
Flag link:
Daily HIV prevention pill urged for healthy people at risk
Daily HIV prevention pill urged for healthy people at risk
Stat
HIV
PrEP
Truvada
Gilead Sciences
Flag link:
Is Gilead Sciences Worth the Wait?
Is Gilead Sciences Worth the Wait?
Motley Fool
Gilead Sciences
Daniel O'Day
Flag link:
3 Cancer Stocks Given a Lift by Amgen
3 Cancer Stocks Given a Lift by Amgen
Motley Fool
Amgen
KRAS
AMG 510
Mirati Therapeutics
Array Biopharma
Gilead Sciences
ASCO 2019
Flag link:
Gilead highlights Yescarta survival data in ASCO update
Gilead highlights Yescarta survival data in ASCO update
Pharmaforum
Gilead Sciences
clinical trials
Yescarta
relapsed or refractory diffuse large B-cell lymphoma
ASCO 2019
Flag link:
Why Is Gilead (GILD) Down 3% Since Last Earnings Report?
Why Is Gilead (GILD) Down 3% Since Last Earnings Report?
Yahoo/Zacks.com
Gilead Sciences
Flag link:
ASCO 2019 day two
ASCO 2019 day two
Pharmaforum
Gilead Sciences
Kite Pharma
KTE-X19
CAR-T
ASCO 2019
Novartis
Merck
Keytruda
spartalizumab
Flag link:
Gilead C-suite shifts again with chief commercial officer appointment
Gilead C-suite shifts again with chief commercial officer appointment
Biopharma Dive
Gilead Sciences
Bristol-Myers Squibb
Flag link:
[sponsored] Life Sciences Matchmaker SOURCE EXPLORER Passes 3,000-Client Milestone

[sponsored] Life Sciences Matchmaker SOURCE EXPLORER Passes 3,000-Client Milestone

CP Wire
life sciences
Source Explorer
Gilead Sciences
Roche
Mylan
Biogen
Genentech
AstraZeneca
Flag link:
[sponsored] Life Sciences Matchmaker SOURCE EXPLORER Passes 3,000-Client Milestone

life sciences
Source Explorer
Gilead Sciences
Roche
Mylan
Biogen
Genentech
AstraZeneca
Flag link:
Better than CAR-T? Already prepping for a US launch, MorphoSys posts stellar DLBCL data to field against Novartis, Gilead
Better than CAR-T? Already prepping for a US launch, MorphoSys posts stellar DLBCL data to field against Novartis, Gilead
Endpoints
CAR-T
MorphoSys
Novartis
Gilead Sciences
tafasitamab
DLBCL
Flag link:
Gilead defends Truvada pricing during House hearing
Gilead defends Truvada pricing during House hearing
BioCentury
Gilead Sciences
Truvada
HIV
drug pricing
US Congress
Flag link:
Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says
Gilead struck anti-competitive deals to bolster profits on an HIV drug, lawsuit says
Stat
Gilead Sciences
AIDS
HIV
generics
competition
Flag link:
Legal Decision Could Open the Doors for Truvada Generic Competition One Year Early, Gilead Says
Legal Decision Could Open the Doors for Truvada Generic Competition One Year Early, Gilead Says
BioSpace
Gilead Sciences
HIV
Truvada
competition
Teva Pharmaceutical
Flag link:
Gilead patent cliff looms as Teva plans generic Truvada launch
Gilead patent cliff looms as Teva plans generic Truvada launch
Pharmaforum
Gilead Sciences
HIV
Truvada
generics
Teva Pharmaceuticals
Flag link:
Gilead will donate meds for US push to end HIV epidemic
Gilead will donate meds for US push to end HIV epidemic
Yahoo/AP
Gilead Sciences
HIV
donations
Truvada
Flag link:
Gilead strikes deal with biotech Goldfinch Bio to tackle kidney diseases
Gilead strikes deal with biotech Goldfinch Bio to tackle kidney diseases
Marketwatch
Gilead Sciences
Goldfinch Bio
drug development
kidney disease
Flag link:
Where Will Gilead Sciences Spend Its Cash?
Where Will Gilead Sciences Spend Its Cash?
Motley Fool
Gilead Sciences
M&A
Atara
Exelixis
Flag link:
5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm
5 Things You Can Expect for Gilead Sciences With Its New CEO at the Helm
Motley Fool
Gilead Sciences
Daniel O'Day
M&A
Kite Pharma
filgotinib
Flag link:

Pages